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Chemical cross-linking in combination with mass spectrometry has emerged as a powerful tool
to study noncovalent protein complexes. Nevertheless, there are still many questions to
answer. Does the amount of detected cross-linked complex correlate with the amount of
protein complex in solution? In which concentration and affinity range is specific cross-linking
possible? To answer these questions, we performed systematic cross-linking studies with two
complexes, using the N-hydroxysuccinimidyl ester disuccinimidyl suberate (DSS): (1) NCoA-1
and mutants of the interacting peptide STAT6Y, covering a KD range of 30 nM to25 M, and
(2) -thrombin and basic pancreatic trypsin inhibitor (BPTI), a system that shows a buffer-
dependent KD value between 100 and 320 M. Samples were analyzed by matrix-assisted laser
desorption/ionization mass spectrometry (MALDI-MS). For NCoA-1•STAT6Y, a good corre-
lation between the amount of cross-linked species and the calculated fraction of complex
present in solution was observed. Thus, chemical cross-linking in combination with
MALDI-MS can be used to rank binding affinities. For the mid-affinity range up to about KD
25 M, experiments with a nonbinding peptide and studies of the concentration dependence
showed that only specific complexes undergo cross-linking with DSS. To study in which
affinity range specific cross-linking can be applied, the weak -thrombin•BPTI complex was
investigated. We found that the detected complex is a nonspecifically cross-linked species.
Consequently, based on the experimental approach used in this study, chemical cross-linking
is not suitable for studying low-affinity complexes with KD  25 M. (J Am Soc Mass
Spectrom 2010, 21, 1775–1783) © 2010 American Society for Mass Spectrometry
The identification and quantitation of protein–protein interactions is the basis for understandingmost cellular pathways. Numerous analytical
techniques have been developed to gain insight into
biochemical communication between proteins, such as
circular dichroism spectroscopy (CD), isothermal titra-
tion calorimetry (ITC), nuclear magnetic resonance
spectroscopy (NMR), surface plasmon resonance (SPR),
light scattering, gel-filtration, or fluorescence polariza-
tion assays (FPA), to name just a few. The ideal method
would yield the stoichiometry and size of a complex, as
well as thermodynamic and kinetic data, and would
allow differentiating between specific and nonspecific
interactions over a broad affinity range. Physiologically
relevant interactions have dissociation constants (KD)
between 1016 and 103 M, which is quite a demanding
dynamic range for any detection method [1, 2].
Chemical cross-linking in combination with electros-
pray ionization (ESI) or matrix-assisted laser desorption/
ionization mass spectrometry (MALDI) mass spectrom-
etry (MS) has emerged as a valuable tool to study
protein–protein or protein–ligand interactions. Top-
down or bottom-up strategies can aid to map binding
interfaces using the cross-linker arm as a ruler to
constrain distances [3, 4]. Chemical cross-linking stabi-
lizes noncovalent complexes, prevents their dissocia-
tion and thus allows rapid identification of interactions
and determination of complex stoichiometry and mass
with minimal sample consumption [5, 6]. During
MALDI ionization, most of the species present in the
sample appear as singly charged pseudo-molecular ions
in the spectra, greatly simplifying the data interpreta-
tion for complex mixtures. In combination with novel
detector technologies, the mass range has been signifi-
cantly extended, to more than 1 MDa, allowing sensi-
tive detection of, for example, immunocomplexes or
protein multimers [7, 8]. Among the most common
cross-linking agents are homobifunctional N-hydroxy
succinimide (NHS) esters, which were introduced more
than 30 years ago and shown to be highly amine-
reactive [9]. The chemical cross-linking step relies upon
an acylation of nucleophilic residues, in particular the
amine groups of lysine or the N-terminus, and hydroxyl
side chains of serine, threonine, or tyrosine [10, 11],
which are accessible on the exterior surface of the
proteins. When working with high protein concentra-
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tions, the probability of unintentionally forming cross-
linked protein multimers as a consequence of nonspe-
cific encounters also increases. Analysis of complexes
after chemical cross-linking by MALDI-MS does not
yield the occupancy of a specific binding site, i.e., this
analytical strategy is susceptible to artifacts due to
nonspecific binding.
The specificity of chemical cross-linking with NHS
esters has been demonstrated in the lower M concen-
tration range using immunocomplexes [7, 12]. Only
specific interactions were found to undergo chemical
cross-linking. For example, Nazabal et al. showed that
incubation of human and bovine serum albumins with
anti-human serum albumin and an NHS cross-linker
yielded a significant antibody-antigen complex peak in
the MALDI mass spectra only for samples containing
human serum albumin [7]. Similarly, sandwich assays
of bovine prion protein containing two different mono-
clonal antibodies were only detected for antibodies
known to interact with the antigen, but not for anti-
glutathione-S-transferase [12]. As demonstrated for
complexes containing the peptide bradykinin and the
corresponding B2 receptor, the application of chemical
cross-linking with homobifunctional NHS esters is lim-
ited by the availability of reactive amino acids [13]. For
the given example, the lack of accessible lysine residues
close to the binding domain increased the fraction of
nonspecific cross-linking. Specific cross-linking was
achieved by using heterobifunctional reagents contain-
ing maleimide and NHS functionality.
Previous research indicated that chemical cross-linking
also has the potential to differentiate between low- and
high-affinity complexes. In studies of the functional
epitope of the urokinase-type plasminogen activator
receptor (uPAR) interacting with the growth factor-like
module of urokinase-type plasminogen activator (uPA),
complexes of alanine mutants of the amino-terminal
fragment of uPA (ATF) and uPAR with dissociation
constants in the low to high nanomolar range were
subjected to chemical cross-linking using disuccinimi-
dyl suberate (DSS). After analysis of the radioactively
labeled and cross-linked samples by SDS-PAGE and
autoradiography, a semiquantitative correlation of
complex levels with kinetic data obtained by surface
plasmon resonance was observed, giving no indication on
its absolute agreement [14, 15]. Chemical cross-linking
with NHS esters in combination with MALDI-MS has
been successfully applied to monitor the effect of small-
molecule ligands on the binding of a coactivator pep-
tide (SRC1) to the human estrogen receptor  ligand
binding domain (hER LBD). A semiquantitative corre-
lation between complex levels in solution and complex
levels detected by MALDI-MS was observed [16].
So far, chemical cross-linking with NHS esters has
mainly been applied to high-affinity protein–protein
complexes with dissociation constants in the picomolar or
low nanomolar range, such as human serum albumin and
its corresponding antibody [7, 17] or calmodulin•melittin
[18]. Few studies report the use of cross-linking to
investigate lower affinity complexes. For example, in
the case of the CRT (189-88)•ERp57 complex (KD 
9.1  3.0 M), chemical cross-linking was used to
confirm the interaction [19]. The authors are not aware
of any study featuring chemical cross-linking of low-
affinity complexes with dissociation constants in the
high micromolar range or investigations dealing with
the application range (in terms of KD) for specific
cross-linking. This work addresses the affinity depen-
dence and the concentration range of specific chemical
cross-linking with NHS esters.
A reference system of the nuclear receptor coactiva-
tor NCoA-1 PAS-B domain and the transactivation
domain of the signal transducer and activator of tran-
scription 6 (STAT6) was chosen. The complex formation
is mediated by the hydrophobic face of the C-terminal
domain of STAT6 with the -helical recognition motif
LXXLL (where L is leucine and X any amino acid) [20].
In Figure 1, a ribbon diagram of NCoA-1 (V259-E367)
complexed with a STAT6 derived peptide (L795-E808)
is shown (PDB ID code 1OJ5). Potentially cross-linkable
lysines close to the binding pocket are highlighted.
Assuming a coupling of the cross-linker to the -amino
group of L794 (not included in 1OJ5) or K804 of the
STAT6 peptide, the lysines K265 and K271 of NCoA-1
should be well within reach for the hydrophobic cross-
linker DSS, which has a spacer arm capable of bridging
N-N distances of 5.58 to 11.42 Å [21].
Figure 1. Ribbon diagram of the NCoA-1•STAT6 complex (PDB
ID code 1OJ5). Lysines close to the binding site that can potentially
be cross-linked are highlighted for the helical STAT6-peptide
(light grey ribbon, L795-E808) and the protein NCoA-1 (dark grey
ribbon, V259-E367). Additionally, the N-terminus of the linear
peptide Stat6Y (L794-G814) would be well within in reach of a
cross-linker linked to K271.
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NCoA-1 (257-385) complexes with alanine or cyclo-
hexyl alanine mutants of STAT6 (L794-G814) derived
peptides had been investigated previously, to derive
their binding affinity by a competitive FPA. The result-
ing KDs cover three orders of magnitude (KD  0.03 
0.015 M to KD  13.3  0.6 M); some mutations
essentially abolished the interaction with NCoA-1
(KD  25 M) [22]. Six different mutants were selected
based on their binding affinities with NCoA-1. The
main emphasis was to cover a wide range of binding
affinities to investigate a possible correlation between
the fraction of complex present in solution and that
detected by chemical cross-linking and MALDI-MS.
With the intention of extending the range of KDs to
above 25 M for this study, a low-affinity complex,
-thrombin and basic pancreatic trypsin inhibitor
(BPTI) with a buffer dependent KD (100 to 320 M) was
selected and chemically cross-linked under different
conditions [23].
Materials and Methods
Materials
The nuclear receptor coactivator NCoA-1 PAS-B do-
main (Mw  14.8 kDa, residues 257–385 of human
NCoA-1) obtained analogous to [22] was dialyzed
against a phosphate buffer (10 mM Na2HPO4/
NaH2PO4/150 mM NaCl, pH 8.0) and the resulting
70-M solution was diluted to 10 to 30 M using the
same buffer. Alanine (A) or cyclohexylalanine (Cha)
mutants of a linear peptide containing STAT6 residues
L794 to G814 (Mw  2.4 kDa) were obtained by
solid-phase peptide synthesis as described previously
[22], dissolved in Milli-Q water (Millipore, Molsheim,
France), and diluted to 10 to 30 M in the same
phosphate buffer. The activity of the protein was con-
firmed by an FPA analogous to [22]. The STAT6 derived
peptide contained a C-terminal tyrosine to aid concen-
tration measurements by UV (STAT6Y). Oxidized bo-
vine insulin chain A, basic pancreatic trypsin inhibitor
(BPTI) and -thrombin were obtained from Sigma-
Aldrich Chemie GmbH (Buchs, Switzerland). All pep-
tide and protein concentrations were determined by
UV-absorption at 280 nm using a NanoDrop 1000
(Thermo Fisher Scientific, Wilmington, DE).
The cross-linker DSS was obtained from Thermo
Fisher Scientific Inc. (Rockford, IL) and sinapinic acid
from Sigma-Aldrich. All commercial solvents and re-
agents were obtained in the highest available purity and
used without additional purification.
Chemical Cross-Linking
For experiments with the NCoA-1•STAT6Y complex,
10 L of 10 M NCoA-1 protein solution were incu-
bated with 10 L of 10 M peptide solution for 10 min
at 2 °C. To investigate the concentration dependence, 10
L of 10, 20, or 30 M coactivator protein solutions
were incubated with equimolar amounts of peptides
mutated with alanine at position 794, 796, or 797,
respectively. As negative controls, 10 L of 10, 20, 30, or
70 M coactivator protein solution were incubated with
equimolar amounts of the nonbinding peptide oxidized
bovine insulin chain A. Ten L of the solution were
mixed with a 50-fold molar excess of DSS dissolved in
dimethylformamide (DMF) at 2, 4, or 6 mg/mL in a
10/1 (vol/vol) ratio. Incubation for 4 h in the tempera-
ture range of 2–8 °C was chosen to ensure a complete
cross-linking reaction and to avoid protein denatur-
ation. The remaining solution was treated as a control
and 1 L of DMF was added. Both control and reaction
solution were quenched with 5 L of 50 mM NH4HCO3
solution and afterwards purified by ZipTip (0.6 L C4
resin; Millipore, Molsheim, France). For experiments
with final protein concentrations exceeding 5 M, the
reaction mixtures and control samples were diluted to
reach a final protein concentration comparable to the
concentrations of the first experiment before ZipTip. In
the case of the -thrombin•BPTI complex, -thrombin
with a final protein concentration of about 20 M was
incubated with an equimolar amount or a 2- to 5-fold
molar excess of BPTI in different buffers (10 mM
Na2HPO4/NaH2PO4 at pH 8.0 with no additional salt,
145 mM tetramethylammonium chloride/5 mM NaCl
or 150 mM NaCl) for 15 min. The high protein concen-
tration was carefully optimized to minimize nonspecific
protein–peptide gas-phase adducts and to obtain rea-
sonable protein peak signals in the mass spectra. How-
ever, the absolute concentration of -thrombin has little
influence on the relative amount of protein–peptide
complex. Nine L of the solution were mixed with a
30-fold molar excess of DSS in a 10/1 (vol/vol) ratio at
room-temperature for different reaction times. For this
experiment, a lower excess had to be chosen for practi-
cal reasons: at the selected peptide concentrations of up
to 100 M, the cross-linker concentration had to be
quite high to maintain a 1:10 volume ratio of protein–
peptide:XL. However, at such high concentrations, sol-
ubility issues occurred when adding the cross-linker to
the aqueous protein solution. No purification was
applied.
Mass Spectrometric Detection
Two commercial MALDI-TOF mass spectrometers equi-
pped with a previously described [24] high-mass detec-
tor (HM1; CovalX AG, Zurich, Switzerland) were em-
ployed: a Reflex III (Bruker Daltonics GmbH, Bremen,
Germany), which was used for the measurements with
NCoA-1 and STAT6Y, and an Axima CFR (Shimadzu/
Kratos, Manchester, UK) for the measurements for BPTI
and -thrombin. Measurements were performed in the
linear positive ion mode using standard instrument
settings. Ionization was initiated by using a nitrogen
laser (337 nm) with pulse energies slightly above the
threshold for ion production. Each mass spectrum was
the average of 100 to 200 laser shots obtained at random
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sample positions. Sinapinic acid was used as a matrix,
dissolved at 10 mg/mL in water/acetonitrile/TFA
(49.95/49.95/0.1, vol/vol/vol). In the case of NCoA-
1•STAT6Y, the matrix solution was mixed with the
quenched and purified reaction mixture in a 1/1 (vol/
vol) ratio. For -thrombin•BPTI, the samples were
directly mixed with the matrix in a 1/1 (vol/vol) ratio.
One L of the mixture was spotted on a stainless steel
plate and allowed to dry under ambient conditions. All
mass spectra were baseline-corrected and smoothed us-
ing a Savitzky-Golay algorithm. Peak integrals were cal-
culated by in-house developed software or OriginPro 8
(Hearne Scientific Software, Chicago, IL, USA).
Results and Discussion
Effect of the Binding Affinity on the Efficiency of
Chemical Cross-linking
To first evaluate whether the binding affinity has any
effect on the fraction of cross-linked complex detected,
the coactivator protein NCoA-1 was incubated with
individual alanine or cyclohexylalanine mutants of
STAT6-derived peptides, with binding affinities cover-
ing three orders of magnitude. The peptides selected
and the corresponding dissociation constants for the
complex with the coactivator protein determined at 298
K by Seitz et al. using a competitive FPA [22] are listed
in Table 1. Given that all mutants form 1:1 complexes
with NCoA-1 at the same binding site and have the
same amount of cross-linkable primary amino groups,
this system is very well suited to study the effect of
binding affinity on chemical cross-linking.
Since the experiments were conducted at tempera-
tures of about T  278  3 K to avoid protein degra-
dation, the KD values had to be adapted to the utilized
reaction conditions using the integrated van’t Hoff eq 1:
KD
T  KD
298K · e
RH298K0
R  1T  1298K (1)
with R being the universal gas constant. For the stan-
dard reaction enthalpy RH298K
0 , a value of 7.63  0.13
kcal mol1 determined by ITC measurements [22] was
assumed. According to eq 1, the equilibrium is shifted
towards the product side with decreasing temperature
in the case of an exothermic reaction (
H 	 0). There-
fore, higher binding affinities, i.e., lower KDs and higher
fractions of complex, are expected for a reaction tem-
perature of 278 K compared with 298 K. The calculated
values of KD
278K are listed in Table 1 as well.
The protein–peptide complexes were chemically
cross-linked with the homobifunctional cross-linker
DSS for 4 h. After quenching and purification, the
cross-linked samples were analyzed by MALDI-ToF-
MS. A CovalX high mass detector was used for all
experiments to avoid detector saturation with low mass
compounds and to ensure similar detection efficiency
over the entire m/z range. In comparison with mass
spectra of control samples without any cross-linker, a
significant amount of cross-linked protein–peptide
complex with a mass of 18 kDa was detected for all
derivatives. In the control spectra, a peak at m/z 14,800
corresponding to ionized NCoA-1 was observed. How-
ever, additional nonspecific gas-phase clusters of
NCoA-1•STAT6Y occurred in some spectra with a
maximum intensity of about 15% (data not shown). The
mass spectra of the cross-linked sample contained a
slightly shifted NCoA-1 peak (due to attached cross-
linker molecules whose other ends were hydrolyzed or
linked to another residue within the same molecule)
and a cross-linked NCoA-1•STAT6Y complex. Addi-
tionally, signals corresponding to 1:2 and 1:3 complexes
were observed in some spectra. Since nonspecific gas-
phase clusters did also occur in the mass spectra for the
solutions without cross-linker, these peaks are assumed
to be nonspecific gas-phase clusters as well. Singly
charged dimer ions of NCoA-1 were observed in low
intensity. Since dimerization of NCoA-1 has not been
reported, and no increase in intensity in the mass
spectra for the cross-linked samples was detected, the
dimer is probably formed by nonspecific gas-phase
clustering. Figure 2a contains MALDI mass spectra of
all cross-linked NCoA-1•STAT6Y complexes. In gen-
eral, a fairly good correlation between the binding
affinity and the amount of cross-linked complex was
found. For high-affinity complexes, a high amount of
cross-linked species was detected, whereas the low-
affinity complexes gave only a low amount of cross-
linked species. Even for the complex with peptide
P797A (proline substituted by alanine, KD
278K  10
Table 1. Selected STAT6Y (L794-G814) mutants and corresponding binding affinities with NCoA-1
Name Sequence Mw exact KD in M (298 K)
a KD in M (278 K)
b
L806Cha LLPPTEQDLTKLChaLEGQGESGY 2440.27 0.03  0.015 0.01  0.38
Q800A LLPPTEADLTKLLLEGQGESGY 2343.22 0.11  0.02 0.04  0.38
P796A LLAPTEQDLTKLLLEGQGESGY 2374.23 0.39  0.04 0.15  0.39
L805A LLPPTEQDLTKALLEGQGESGY 2358.20 3.44  0.2 1.36  0.65
L794A ALPPTEQDLTKLLLEGQGESGY 2358.20 13.3  0.6 5.3  1.7
P797A LLPATEQDLTKLLLEGQGESGY 2374.23 25 10  1
Mutated amino acids are marked in bold. The peptide names correspond to the mutated amino acid. The normal amino acid code is used; Cha 
L-cyclohexylalanine.
aKD values determined by a competitive FPA at 298 K were taken from reference [22].
bKD values at 278 K were calculated using the van’t Hoff equation and thermodynamic data from [22].
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M), the chemical cross-linking procedure yielded a
significant amount of a protein–peptide adduct, which
suggests the formation of a specifically stabilized complex.
The areas of the cross-linked complexes were nor-
malized by the total peak area of the coactivator protein,
RXL  100  [NCoA-1•STAT6Y]/([NCoA-1•STAT6Y] 
[NCoA-1]), neglecting the 1:2 and 1:3 complexes. The
fraction of cross-linked complex, RXL, calculated in this
fashion was compared with the theoretically calculated
fraction of protein–peptide complex in solution, Rth,
based on the known KD values and the protein and
peptide concentrations determined by UV measure-
ments. Rth was estimated using eqs 2 and 3 below. The
dissociation constant KD is defined as
KD 
[A]eq · [B]eq
[A • B]eq
(2)
where [A]eq, [B]eq, and [A•B]eq are the NCoA-1, the
STAT6Y and the NCoA-1•STAT6Y complex concentra-
tions at equilibrium, respectively. With [A]eq  [A]0 
[A•B]eq and [B]eq  [B]0 – [A•B]eq, where [A]0 and [B]0
are the total concentrations of NCoA-1 and STAT6Y
used, the fraction of protein–peptide complex Rth at
equilibrium can be calculated with eq 3:
Rth 
100
[A]0
[A]0  [B]0  KD278K
2
[A]0  [B]0  KD278K24  [A]0 · [B]0	
1
2	 (3)
A comparison of Rth and RXL is shown in Figure 2b. For
most of the peptides, less complex was detected com-
pared with the theoretical value. There can be different
reasons for this behavior: (1) the protein may be par-
tially inactive due to addition of the cross-linker dis-
solved in DMF and (2) the efficiency of chemical cross-
linking may not be sufficient to stabilize all complexes
present in solution. For instance, a reaction of a partially
hydrolyzed cross-linker with the protein or peptide at a
position close to the binding interface will not yield a
cross-linked complex and thus decreases the observed
fraction of cross-linked complex. Nevertheless, a rea-
sonable agreement of the trend of RXL as a function of
KD with that of Rth was found.
We also estimated error bars based on the following
uncertainties: for the concentration measurement by
UV, the error resulting from the sum of absorbance
accuracy and reproducibility of the NanoDrop is about
10%. Additionally, an estimated absorption coefficient 

(http://expasy.org/) was used. Although only a mini-
mum laser power at the detection limit and a final
protein concentration of 5 M was used to obtain the
spectra of the control and the cross-linked samples,
nonspecific adduct ions could not be avoided. These
aggregates of simultaneously desorbed molecular spe-
cies are formed as a consequence of clustering in the
expanding desorption plume and do not reflect the
binding affinities in solution [25]. For the control sam-
ples without cross-linker, protein–peptide adducts were
observed in some cases, with a relative peak intensity
up to 15% (data not shown). For the mass spectra of
cross-linked samples, cross-linked complexes aggre-
gated with one or two additional STAT6Y peptides
occurred from time to time (Figure 2a). Because of this
adduct formation, quantitative analysis of the fraction
of cross-linked complex by MALDI-MS is slightly ham-
Figure 2. (a) Effects of binding affinity on the relative amount
of cross-linked protein–peptide complex as determined with
MALDI-MS after cross-linking; (b) Comparison with theoretically
calculated values for the solution phase equilibrium based on KD
278K
values specified in Table 1. For the calculations, a dissociation
constant KD
278K  10 M was assumed for the peptide P797A. For
RXL, y error bars correspond to an estimated error of 
R  10%,
and x error bars were calculated assuming cNCoA-1  cStat6Y  5 
0.5 M. The error of Rth is shown as light grey curve.
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pered. Based on measured standard deviations for the
relative complex amount and the presence of nonspe-
cific gas-phase adducts, an estimated error of 10% was
used for RXL for all peptides, since the actual error is
probably larger than merely the standard deviations.
For MALDI mass spectrometry, the signal intensity
of any species is highly dependent on its ionization
efficiency, which may differ for a protein and its corre-
sponding protein–ligand complex. If the protein–ligand
complexes have comparable ionization efficiencies and
are still detectable, a semiquantitative ranking of bind-
ing affinities should still be possible. In the case of
NCoA-1•STAT6Y, normalized peak intensities of the
protonated peptide were compared in the MALDI mass
spectra for each peptide using L806Cha as an internal
standard. Within error, no substantial difference in
peak intensity was observed (data not shown). Thus,
comparable ionization efficiencies of the NCoA-1•
STAT6Y complexes are expected.
The RXL values of L794A and P797A exhibited a
closer match between measured and theoretical com-
plex amounts for the mutants. Two main reasons are
believed to be responsible for that: (1) since nonspecific
gas-phase clusters occurred in the control spectra (with-
out cross-linker) with a relative intensity of up to 15%,
an overlap of cross-linked complex peaks and nonspe-
cific gas-phase adducts is likely. The influence of un-
specific adducts plays a more important role for the
low-affinity complexes since the relative error of RXL
based on nonspecific clusters is much higher than for
the high-affinity complexes; (2) the peaks of the protein
and the cross-linked protein–peptide complex are not
perfectly resolved. Since the integration limits were
chosen at the minimum intensity between these peaks,
the amount of cross-linked complex is probably over-
estimated for the low-affinity complexes.
Nevertheless, the observed correlations between the
binding affinity and the amount of cross-linked com-
plex in the present study and previous investigations
led to the assumption that chemical cross-linking in
combination with MALDI-MS is a valuable tool to rank
binding affinities with dissociation constants in the
nanomolar and low micromolar range.
Considerations on the Disturbance of the Chemical
Equilibrium
Preferably, a method for the analysis of protein–protein
interactions would yield not only relative but also
absolute complex levels to provide thermodynamic
parameters such as dissociation constants. Our data
revealed lower complex levels than predicted by solu-
tion phase equilibria. In another study dealing with the
domain interplay of uPAR, the detected amount of
cross-linked uPAR-ATF complex exceeded the level
predicted from the equilibrium binding situation after
15 min cross-linking reaction at pH 7.4 [26]. In contrast,
Bich et al. detected complex levels of about 90% of the
predicted values on average after chemical cross-linking
with the amine reactive homobifunctional cross-linker
1,1=-(suberoyldioxy)bisazabenzotriazole (SBAT) and
MALDI-MS detection [27]. The question arises whether
the chemical stabilization of the noncovalent complex
can disturb the solution phase equilibrium and, if so,
under which conditions a shift could be expected.
The NHS ester does not only react with A•B, but also
with the unbound A and B and thus changes the
concentrations of free [A]eq and [B]eq as well (see
Scheme 1). To discuss potential equilibrium shifts, the
following simplifications were made: (1) the cross-
linking rates for A, B, and A•B are assumed to be
similar and to follow pseudo-first-order kinetics
(kXL
1  kXL
2  kXL
3 ), (2) only reaction sites close to the
binding pocket with a similar number of reactive amino
acids for all binding partners are considered, and (3)
hydrolysis of the second end of a cross-linker bound to
free A or B is assumed to be complete before an
appropriate binding partner is encountered (kon
2  0 in
Scheme 1). Assumption (3) was confirmed with exper-
imental data. Ten min of separated cross-linking of
NCoA-1 and STAT6Y before mixing were sufficient to
decrease the amount of cross-linked complex to a min-
imum after combining the two solutions (data not
shown). Based on these assumptions, the numerator of
eq 2, i.e., the product of [A]eq and [B]eq, would decrease
faster than the denominator. According to Le Chat-
elier’s principle, the system would try to adjust the
concentrations back to the equilibrium conditions by
enhanced formation of reactants, i.e., dissociation of the
complex.
KD equals koff/kon, where koff and kon are the kinetic
constants for dissociation and association, respectively.
Consequently, high-affinity complexes should be less
affected by the enhanced dissociation reaction due to
their low koff, since the re-establishment of the equilib-
rium conditions would last longer. In the case of
low-affinity complexes, the high koff values would
Scheme 1. Simplified scheme of reactions occurring during
cross-linking of a protein–peptide complex; kXL designates the
global kinetic constants of the reactions with the cross-linking
agent, kon indicates an association reaction, and koff the dissocia-
tion of the noncovalent complex.
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allow a fast dissociation reaction and thus a lower
fraction of cross-linked complex would be detected
compared to the original equilibrium conditions. How-
ever, when using very efficient cross-linkers with cross-
linking rate constants larger than koff and high cross-
linker excess, this concentration shift would probably
not be significant, as we suppose for our data. To
generate cross-linked complex levels exceeding the the-
oretical complex amounts, low cross-linker hydrolysis
rates leading to kon
2  0 or kXL
3  kXL
1 , kXL
2 would be
required. In summary, we only would expect major
deviations of the detected cross-linked complex levels
from the solution phase state for complexes without
reactive amino acids close to the binding pocket, for
high complex dissociation rates, or for special reaction
conditions.
Consequently, the best agreement with solution
phase levels should occur for extremely efficient cross-
linkers with high reaction speed, high reactivity to-
wards different amino acids, and sufficient compatibil-
ity with MALDI-MS. These requirements would be
partially fulfilled with the recently introduced homobi-
functional cross-linker SBAT [28]. The presence of esteri-
fied 1-hydroxy-7-azabenzotriazoles as reactive groups
generated about 30% more cross-linked complex, and
resulted in reaction rates 10 times higher compared
with DSS. In experiments comparing reaction yields of
small peptides bearing only one reactive group, SBAT
showed higher reactivity towards tyrosine than DSS.
However, a comparable specificity to that of DSS was
observed for the cross-linking of glutathione-S-transferase
(GST) dimer at 5 M concentration in the presence of
3-fold molar excess of bovine ubiquitin.
Specificity as a Function of Concentration
Since the cross-linker reacts simply with reactive amino
acid side chains in close proximity and does not differ-
entiate whether the reaction partners are participants in
a specific noncovalent interaction, nonspecific cross-
linking of proteins is possible. As the concentrations of
the biomolecules increase, the probability of a cross-
linking reaction between two nonbinding molecules
increases.
To prove that the observed cross-linked NCoA-
1•STAT6Y species is a specific complex, and to inves-
tigate the concentration range of this specificity, three
different peptide mutants were chosen and their reac-
tion behavior with the chemical cross-linker DSS was
investigated for three different protein concentrations,
maintaining a 1:1 protein:peptide ratio. The relative
amount of cross-linked complex RXL was determined as
described above and compared with the Rth values of
the relative protein complex amount in solution. The
resulting concentration dependence is depicted in Fig-
ure 3. Again, a fairly good correlation between mea-
sured and theoretical values was observed. As ex-
pected, P797A, having the lowest affinity, showed a
slightly lower ratio of experimental versus theoretical
complex amounts, since the actual KD
278K exceeds the
value of 10 M assumed for the calculations. We
suppose that with increasing concentration the amount
of cross-linked species that represent nonspecific inter-
actions increases. However, the slope of the measured
values is (within error bars) not significantly larger than
the slope of the theoretical values. Thus, the amount of
nonspecifically cross-linked species can be neglected
and the specificity of chemical cross-linking can be
extended to a concentration of 15 M for this system.
Negative Control Experiments with a Nonbinding
Peptide
As a negative control, the reaction behavior of the
cross-linker and NCoA-1 in the presence of a nonbind-
ing peptide was tested as well. Oxidized insulin chain A
was selected as a reference compound, since its molec-
ular weight of 2.5 kDa and thus its diffusion coefficient
is quite similar to that of the mutated peptides of
STAT6Y. Mixtures of protein and peptide in a 1:1 M
ratio were subjected to chemical cross-linking and ana-
lyzed by MALDI-MS. As illustrated in Figure 4, no
significant amount of a cross-linked complex between
the coactivator protein and the insulin peptide was
observed. Visible adduct peaks have about the same
intensity as in the control spectra (shown in grey). Even
at higher protein and peptide concentrations (35 M),
no significant amount of cross-linked complex was
detected. Consequently, chemical cross-linking requires
a specific interaction between the coactivator protein
NCoA-1 and a peptide. No unspecific cross-linking
occurred under the described reaction conditions.
Figure 3. Effects of different NCoA-1•STAT6Y concentrations
on the amount of cross-linked complex detected by MALDI-MS
for the peptides P797A (KD
278K 10 1 M), P796A (KD
278K 0.15
0.39 M), L794A (KD
278K  5.3  1.7 M): Comparison of relative
amounts of cross-linked complex RXL derived from the MALDI
mass spectra of the reaction mixtures (light grey columns) with
theoretically calculated values for the solution phase equilibrium
based on KD
278K (dark grey columns) Rth. The concentrations given
on the top correspond to the resulting protein concentration in the
equimolar protein–peptide mixture. For RXL, an absolute error of

R  10% was estimated. Error bars for Rth were calculated with
the Gaussian law of errors.
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Cross-Linking of Weak Complexes
As discussed above, a noncovalent complex of NCoA-
1•STAT6Y with KD
298K  25 M could be chemically
stabilized and detected by MALDI-MS with no indica-
tion of nonspecific cross-linking. However, a number of
cellular processes involve even weaker complexes.
Physiologically relevant interactions as weak as KD 
104 to 103 M are largely overlooked by most analyt-
ical techniques such as ITC, X-Ray crystallography, or
SPR. One approach to detect such fragile complexes is
NMR, as reviewed in reference [2]. To test whether
chemical cross-linking with MALDI-MS could be used
to specifically detect weak protein–protein interactions,
experiments with the weak -thrombin•BPTI complex
were conducted. BPTI (m/z 6500) binding to -thrombin
(m/z 36,000) is dependent on the sodium ion concentra-
tions, which affect the conformational state of -thrombin
[29]. Whereas a concentration of 150 mM NaCl yields a
KD of 100 M, the dissociation constant decreases to 320
M when 5 mM NaCl with 145 mM tetramethylammo-
nium chloride (TMACl) is present in the buffer (10 mM
Tris/HCl with 0.1% PEG 6000 at pH 8 in both cases) [23].
To detect a significant amount of protein complex, a
relatively high excess of BPTI is necessary. Since Rth and
RXL are relative measures related to the total amount of
-thrombin in solution, the absolute concentration of
-thrombin has little influence on both R values. In
contrast, variations of the BPTI concentration cause a
significant variation of R. For KD 320 M, Rth is about
5% for 20 M BPTI concentration, whereas at 100 M
concentration a relative amount of -thrombin•BPTI of
23% is expected. An -thrombin concentration of about
23 M was chosen to reduce the risk of signal suppres-
sion for -thrombin related signals. Surprisingly, few
unspecific gas-phase adducts were observed in the
MALDI mass spectra for the conditions chosen, which
simplified spectra interpretation significantly. Cross-
linking experiments were first performed at different
BPTI concentrations ranging from 20 to 100 M in 10
mM Na2HPO4/NaH2PO4 at pH 8.0 with no additional
salt. Significant amounts of cross-linked -thrombin•
BPTI were detected above 40 M. Cross-linking times of
4 h at room temperature yielded RXL values of about
50% of Rth (data not shown). For longer reaction times
of 24 h, RXL even exceeded Rth by 100%, indicating
unspecific complex formation for BPTI concentrations
of 40 and 60 M (for higher concentrations spectra
quality decreased dramatically after 24 h cross-linking
due to the higher concentration of cross-linker present
in solution). With the addition of 150 mM NaCl or 145
mM TMACl with 5 mM NaCl to the buffer, no signifi-
cant changes of RXL were observed within error. All the
described results indicate that at concentrations above
40 M, nonspecific cross-linking is favored. Addition-
ally, control experiments with the same BPTI concen-
trations but no -thrombin present in solution yielded
cross-linked BPTI dimers, trimers, and tetramers after
24 h of cross-linking, whose extent could be correlated
with the BPTI concentration. In summary, chemical
cross-linking in combination with MALDI-MS is unsuit-
able for weak complexes with the experimental proce-
dure described above.
Conclusions
The observed correlation between the binding affinity
and the fraction of cross-linked complex in the mid-
affinity range suggests that chemical cross-linking in
combination with MALDI-MS can be used to rank
binding affinities. Specific complexes could be detected
up to protein and peptide concentrations of 35 M.
However, for low-affinity complexes in the 104 M KD
range, the simple protocol that includes the cross-linking
step followed by direct analysis with MALDI-MS cannot
be applied. A more sophisticated protocol would be
necessary, using, for example, much lower concentra-
tions for cross-linking and subsequent enrichment of
the protein and protein–peptide complex. For all exper-
iments performed in this work, comparable conditions
for chemical cross-linking were utilized; i.e., compara-
ble numbers of cross-linkable amino acids were present.
Additionally, only one cross-linker, targeting mainly
primary amines, was tested. However, the need for
specific amino acids as targets for a certain cross-linking
agent can restrict the application range of this method,
especially when the chemical structure of the ligands is
considerably different. To use chemical cross-linking
and mass spectrometry to study the binding affinity of
an unknown sample, experiments using a variety of
cross-linkers with different spacer lengths and reactive
Figure 4. Effects of NCoA-1 concentrations on the amount of
cross-linked complex detected by MALDI-MS for the nonbinding
peptide oxidized insulin chain A. The grey curves correspond to
the MALDI mass spectra of control mixtures without any cross-
linker. The grey curves are the MALDI mass spectra of the
reaction mixture containing a 50-fold molar excess of cross-linker.
No cross-link between NCoA-1 and the insulin peptide was
observed after an incubation time of 4 h.
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groups have to be performed. For the measurements
described herein, a 30- and 50-fold excess of cross-linker
was used. When dealing with unknown protein com-
plexes, optimization experiments to generate a maximum
amount of cross-linked complex with a minimal cross-
linker concentration are suggested.
We suggest that chemical cross-linking in combina-
tion with MALDI-MS could also rank binding affinities
of proteins binding multiple ligands. The main prereq-
uisite would again be a comparable availability of
cross-linkable amino acids close to the binding inter-
face. However, since this study is the first one dealing
with chemical cross-linking and MALDI-MS over a
broad range of binding affinities, the investigation of
“higher-order complexes“ is far beyond the scope of
this work and will be the subject of future research.
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